Immunovant Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K May 29, 2025 8-K
144 May 21, 2025
144 May 19, 2025
4 May 5, 2025
4 May 5, 2025
4 May 5, 2025
S-8 Apr 30, 2025 S-8
3 Apr 28, 2025
3 Apr 28, 2025
3 Apr 28, 2025
4 Apr 25, 2025 FORM 4
4 Apr 25, 2025 FORM 4
SCHEDULE 13D/A Apr 21, 2025
8-K Apr 21, 2025 8-K
4 Apr 17, 2025 FORM 4
4 Apr 17, 2025 FORM 4
4 Apr 11, 2025 FORM 4
4 Apr 11, 2025 FORM 4
4 Apr 11, 2025 FORM 4
4 Apr 11, 2025 FORM 4
4 Apr 3, 2025 FORM 4
4 Apr 3, 2025 FORM 4
4 Apr 3, 2025 FORM 4
4 Apr 3, 2025 FORM 4
4 Apr 3, 2025 FORM 4
← Newer Page 5 of 26 · 641 filings Older →